Tearsheet

Addus HomeCare (ADUS)


Market Price (6/21/2026): $94.19 | Market Cap: $1.7 BilSector: Health Care | Industry: Health Care Services

Addus HomeCare (ADUS)


Market Price (6/21/2026): $94.19
Market Cap: $1.7 Bil
Sector: Health Care
Industry: Health Care Services

Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.

0

Attractive yield
Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 5.8%, FCF Yield is 8.0%

Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 10%

Low stock price volatility
Vol 12M is 31%

Megatrend and thematic drivers
Megatrends include Aging Population & Chronic Disease, and Digital Health & Telemedicine. Themes include Geriatric Care, Remote Patient Monitoring, Show more.

Weak multi-year price returns
2Y Excs Rtn is -57%, 3Y Excs Rtn is -72%

Key risks
ADUS key risks include [1] the potential failure to successfully integrate acquisitions and achieve anticipated synergies from its M&A-focused growth strategy.

0 Attractive yield
Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 5.8%, FCF Yield is 8.0%
1 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 10%
2 Low stock price volatility
Vol 12M is 31%
3 Megatrend and thematic drivers
Megatrends include Aging Population & Chronic Disease, and Digital Health & Telemedicine. Themes include Geriatric Care, Remote Patient Monitoring, Show more.
4 Weak multi-year price returns
2Y Excs Rtn is -57%, 3Y Excs Rtn is -72%
5 Key risks
ADUS key risks include [1] the potential failure to successfully integrate acquisitions and achieve anticipated synergies from its M&A-focused growth strategy.

ADUS in ETFs

Weight = ADUS's share of each fund

VTI0.00%
ITOT0.00%
IWM0.05%
IJR0.11%
IHF0.24%
IJT0.14%
SLYG0.13%
IJS0.07%
+14 more covered ETFs

Valuation & Metrics

Price Chart

Why The Stock Moved

Qualitative Assessment

AI Analysis | Feedback

Updated on 6/15/2026

Addus HomeCare (ADUS) stock has lost about 10% since 2/28/2026 because of the following key factors:

1. Addus HomeCare's fiscal Q1 2026 revenue fell short of analyst expectations, contributing to a post-earnings stock decline. The company reported net service revenues of $363.6 million for fiscal Q1 2026, which ended March 31, 2026, missing analyst estimates of $366.41 million (or $373.5 million by other estimates). Despite an adjusted earnings per share (EPS) beat of $1.62 against a consensus of $1.52 (or $1.58), the revenue miss led to a negative market reaction, with the stock falling approximately 3.5% after the earnings release on May 4, 2026.

2. Ongoing macroeconomic and industry-specific cost pressures, coupled with potential reimbursement risks, weighed on investor sentiment in the healthcare sector. The broader U.S. healthcare system, including home care providers like Addus, continues to face structural challenges such as rising costs, persistent workforce shortages, and increasing complexity. Analysts have highlighted that Addus HomeCare's Medicaid and Medicare-funded personal care model must demonstrate resilience against these reimbursement and labor pressures, with state policy changes affecting rates and potential reductions in Medicare reimbursement rates posing risks to margins.

Show more
Updated on 6/15/2026

Addus HomeCare (ADUS) stock has lost about 10% since 2/28/2026 because of the following key factors:

1. Addus HomeCare's fiscal Q1 2026 revenue fell short of analyst expectations, contributing to a post-earnings stock decline. The company reported net service revenues of $363.6 million for fiscal Q1 2026, which ended March 31, 2026, missing analyst estimates of $366.41 million (or $373.5 million by other estimates). Despite an adjusted earnings per share (EPS) beat of $1.62 against a consensus of $1.52 (or $1.58), the revenue miss led to a negative market reaction, with the stock falling approximately 3.5% after the earnings release on May 4, 2026.

2. Ongoing macroeconomic and industry-specific cost pressures, coupled with potential reimbursement risks, weighed on investor sentiment in the healthcare sector. The broader U.S. healthcare system, including home care providers like Addus, continues to face structural challenges such as rising costs, persistent workforce shortages, and increasing complexity. Analysts have highlighted that Addus HomeCare's Medicaid and Medicare-funded personal care model must demonstrate resilience against these reimbursement and labor pressures, with state policy changes affecting rates and potential reductions in Medicare reimbursement rates posing risks to margins.

3. An analyst downgrade within the period likely impacted investor confidence and contributed to the stock's downward trend. On May 15, 2026, Barclays maintained a "Sell" rating on Addus HomeCare and lowered its price target from $102 to $92, indicating a more cautious outlook on the company's future performance. Such a downgrade from a notable firm can negatively influence market perception and share price, especially when reinforcing existing concerns about the sector.

Show less
Holding a concentrated position? Know your true downside before the momentum shifts.
Protect Your Wealth →

Stock Movement Drivers

Fundamental Drivers

The -9.0% change in ADUS stock from 2/28/2026 to 6/21/2026 was primarily driven by a -12.2% change in the company's P/E Multiple.
(LTM values as of)22820266212026Change
Stock Price ($)103.5394.19-9.0%
Change Contribution By: 
Total Revenues ($ Mil)1,4231,4481.8%
Net Income Margin (%)6.7%6.9%2.1%
P/E Multiple19.617.2-12.2%
Shares Outstanding (Mil)1818-0.4%
Cumulative Contribution-9.0%

LTM = Last Twelve Months as of date shown

Market Drivers

2/28/2026 to 6/21/2026
ReturnCorrelation
ADUS-9.0% 
Market (SPY)9.2%15.8%
Sector (XLV)-6.4%18.1%

Fundamental Drivers

The -21.6% change in ADUS stock from 11/30/2025 to 6/21/2026 was primarily driven by a -32.3% change in the company's P/E Multiple.
(LTM values as of)113020256212026Change
Stock Price ($)120.2094.19-21.6%
Change Contribution By: 
Total Revenues ($ Mil)1,3471,4487.6%
Net Income Margin (%)6.4%6.9%8.3%
P/E Multiple25.417.2-32.3%
Shares Outstanding (Mil)1818-0.7%
Cumulative Contribution-21.6%

LTM = Last Twelve Months as of date shown

Market Drivers

11/30/2025 to 6/21/2026
ReturnCorrelation
ADUS-21.6% 
Market (SPY)9.9%4.3%
Sector (XLV)-4.4%22.9%

Fundamental Drivers

The -15.1% change in ADUS stock from 5/31/2025 to 6/21/2026 was primarily driven by a -31.9% change in the company's P/E Multiple.
(LTM values as of)53120256212026Change
Stock Price ($)110.9194.19-15.1%
Change Contribution By: 
Total Revenues ($ Mil)1,2121,44819.6%
Net Income Margin (%)6.5%6.9%5.6%
P/E Multiple25.217.2-31.9%
Shares Outstanding (Mil)1818-1.2%
Cumulative Contribution-15.1%

LTM = Last Twelve Months as of date shown

Market Drivers

5/31/2025 to 6/21/2026
ReturnCorrelation
ADUS-15.0% 
Market (SPY)28.1%18.2%
Sector (XLV)14.6%25.3%

Fundamental Drivers

The 4.5% change in ADUS stock from 5/31/2023 to 6/21/2026 was primarily driven by a 48.4% change in the company's Total Revenues ($ Mil).
(LTM values as of)53120236212026Change
Stock Price ($)90.1594.194.5%
Change Contribution By: 
Total Revenues ($ Mil)9761,44848.4%
Net Income Margin (%)5.1%6.9%33.8%
P/E Multiple28.617.2-40.0%
Shares Outstanding (Mil)1618-12.3%
Cumulative Contribution4.5%

LTM = Last Twelve Months as of date shown

Market Drivers

5/31/2023 to 6/21/2026
ReturnCorrelation
ADUS4.5% 
Market (SPY)85.7%28.2%
Sector (XLV)22.9%28.0%

Return vs. Risk

Price Returns Compared

 202120222023202420252026Total [1]
Returns
ADUS Return-20%6%-7%35%-14%-13%-20%
Peers Return15%-18%72%21%50%5%207%
S&P 500 Return27%-19%24%23%16%8%98%

Monthly Win Rates [3]
ADUS Win Rate33%50%50%67%58%50% 
Peers Win Rate50%42%62%58%55%57% 
S&P 500 Win Rate75%42%67%75%67%50% 

Max Drawdowns [4]
ADUS Max Drawdown-43%-25%-31%-12%-34%-25% 
Peers Max Drawdown-25%-50%-23%-25%-30%-29% 
S&P 500 Max Drawdown-5%-25%-10%-8%-19%-9% 


[1] Cumulative total returns since the beginning of 2021
[2] Peers: ENSG, AVAH, CHE, BTSG, OPCH. See ADUS Returns vs. Peers.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 6/18/2026 (YTD)

How Low Can It Go

EventADUSS&P 500
2025 US Tariff Shock
  % Loss-20.7%-18.8%
  % Gain to Breakeven26.0%23.1%
  Time to Breakeven67 days79 days
Summer-Fall 2023 Five Percent Yield Shock
  % Loss-13.6%-9.5%
  % Gain to Breakeven15.7%10.5%
  Time to Breakeven34 days24 days
2023 SVB Regional Banking Crisis
  % Loss-24.4%-6.7%
  % Gain to Breakeven32.2%7.1%
  Time to Breakeven370 days31 days
2022 Inflation Shock & Fed Tightening
  % Loss-24.8%-24.5%
  % Gain to Breakeven32.9%32.4%
  Time to Breakeven148 days427 days
2020 COVID-19 Crash
  % Loss-51.4%-33.7%
  % Gain to Breakeven105.9%50.9%
  Time to Breakeven139 days140 days
2015-2016 China Devaluation / Global Growth Scare
  % Loss-42.6%-12.2%
  % Gain to Breakeven74.3%13.9%
  Time to Breakeven236 days62 days

Compare to ENSG, AVAH, CHE, BTSG, OPCH

In The Past

Addus HomeCare's stock fell -20.7% during the 2025 US Tariff Shock. Such a loss loss requires a 26.0% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

EventADUSS&P 500
2025 US Tariff Shock
  % Loss-20.7%-18.8%
  % Gain to Breakeven26.0%23.1%
  Time to Breakeven67 days79 days
2023 SVB Regional Banking Crisis
  % Loss-24.4%-6.7%
  % Gain to Breakeven32.2%7.1%
  Time to Breakeven370 days31 days
2022 Inflation Shock & Fed Tightening
  % Loss-24.8%-24.5%
  % Gain to Breakeven32.9%32.4%
  Time to Breakeven148 days427 days
2020 COVID-19 Crash
  % Loss-51.4%-33.7%
  % Gain to Breakeven105.9%50.9%
  Time to Breakeven139 days140 days
2015-2016 China Devaluation / Global Growth Scare
  % Loss-42.6%-12.2%
  % Gain to Breakeven74.3%13.9%
  Time to Breakeven236 days62 days
2014-2016 Oil Price Collapse
  % Loss-21.0%-6.8%
  % Gain to Breakeven26.6%7.3%
  Time to Breakeven50 days15 days
2011 US Debt Ceiling Crisis & European Contagion
  % Loss-44.8%-17.9%
  % Gain to Breakeven81.1%21.8%
  Time to Breakeven399 days123 days

Compare to ENSG, AVAH, CHE, BTSG, OPCH

In The Past

Addus HomeCare's stock fell -20.7% during the 2025 US Tariff Shock. Such a loss loss requires a 26.0% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Addus HomeCare (ADUS)

Addus HomeCare Corporation (ADUS) is a leading provider of comprehensive in-home healthcare services across the United States. The company's core mission is to support elderly, chronically ill, or disabled individuals, as well as those who are terminally ill, by delivering essential care in their homes. This approach helps these individuals maintain independence, improve their quality of life, and often prevents the need for hospitalization or institutionalization. Addus operates through three primary segments, each addressing distinct needs within the homecare spectrum.

The company's main services include Personal Care, Hospice, and Home Health. The Personal Care segment offers non-medical assistance with daily living activities, such as bathing, grooming, meal preparation, medication reminders, housekeeping, and transportation. The Hospice segment focuses on providing palliative nursing care, social work, spiritual counseling, and bereavement support for terminally ill individuals and their families. Lastly, the Home Health segment delivers skilled nursing care along with physical, occupational, and speech therapy services for individuals recovering from illness or hospitalization.

Addus HomeCare serves a diverse client base, including federal, state, and local governmental agencies, managed care organizations, and commercial insurers, as well as private individuals who pay for services directly. The company's extensive network spans 22 states, where it operates through 206 offices, allowing it to provide vital care to a broad population across various regions of the country.

AI Analysis | Feedback

Think of Addus HomeCare as **Home Instead Senior Care**, but also offering professional medical home health and hospice services.

Imagine it like **Teladoc or MDLive**, but for a broad range of in-person home care services, including personal assistance, skilled nursing, and hospice.

Consider it like **Uber or Lyft**, but for dispatching trained caregivers and nurses directly to people's homes to provide a spectrum of personal, medical, and hospice care services.

AI Analysis | Feedback

```html
  • Personal Care Services: Provides non-medical assistance with daily living activities such as bathing, grooming, feeding, medication reminders, meal preparation, housekeeping, and transportation.
  • Hospice Services: Offers palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling for terminally ill individuals and their families.
  • Home Health Services: Delivers skilled nursing and physical, occupational, and speech therapy for individuals requiring assistance during an illness or after hospitalization.
```

AI Analysis | Feedback

Addus HomeCare (ADUS) primarily serves individuals who require assistance with daily living, palliative care, or skilled nursing and therapy during illness or post-hospitalization. Based on the company's description of who it provides services to, its major customers fall into the following categories:

  • Elderly persons
  • Chronically ill persons
  • Disabled persons

AI Analysis | Feedback

null

AI Analysis | Feedback

Dirk Allison, Chairman and Chief Executive Officer

Dirk Allison joined Addus HomeCare as President and Chief Executive Officer in January 2016 and was named Chairman of the Board and Chief Executive Officer in March 2021, having served on its board of directors since 2010. He brings over 29 years of leadership experience in various healthcare segments. His prior roles include President and CEO of Correctional Healthcare Companies, Inc. from 2013 to 2014, and President and CEO of CCS Medical, Inc. from 2011 to 2013. Earlier, he was Senior Vice President, Chief Financial Officer, and Treasurer of Odyssey Healthcare, Inc., which was acquired by Gentiva Health Services, Inc. in 2010. He also held executive finance positions at Omniflight, Inc., Ardent Health Services LLC, and Renal Care Group, Inc., and served as President and CEO of several publicly and privately held companies between 1987 and 1999. His experience includes leadership at Oceans Healthcare, a private equity-backed behavioral healthcare provider, indicating a pattern of managing companies with private equity backing.

Brian Poff, Executive Vice President and Chief Financial Officer

Brian Poff became Executive Vice President and Chief Financial Officer in May 2016, bringing over 16 years of accounting and finance experience primarily in public and private healthcare organizations. Prior to Addus, he was Chief Financial Officer and Treasurer of Oceans Healthcare, a private equity-backed behavioral health care provider. He also served as Senior Vice President of Finance and Chief Accounting Officer for CCS Medical, Corporate Controller for AccentCare, Inc., and Division Chief Financial Officer for Hospice Services at Gentiva Health Services. Poff was Assistant Controller for Odyssey HealthCare, Inc., which was acquired by Gentiva Health Services, and Controller for Horizon Health Corporation until its acquisition by Psychiatric Solutions, Inc. His background includes managing companies with private equity backing.

Heather Dixon, President and Chief Operating Officer

Heather Dixon was appointed President and Chief Operating Officer in September 2025. A Certified Public Accountant, she previously served as Chief Financial Officer of Acadia Healthcare and held positions as Chief Financial Officer and interim Chief Operating Officer at Everside Health. Her career also includes senior leadership roles as Senior Vice President, Global Controller and Chief Accounting Officer for Walgreens Boots Alliance, Inc. and Vice President, Controller and Chief Accounting Officer for Aetna. She began her professional career at PricewaterhouseCoopers and served as an independent board member of Signify Health until its acquisition by CVS Health in March 2023.

Darby Anderson, Executive Vice President and Chief Government Relations Officer

Darby Anderson joined Addus HomeCare in 1996 as Midwest Regional Manager, progressing to Regional Vice President of Midwest/East in 2000, and serving as Senior Vice President until December 2014. He is currently Executive Vice President and Chief Government Relations Officer. Anderson has also held board and advisory committee positions, including with the Older Adult Services Advisory Committee and the Community Care Program Advisory Committee in Illinois.

Sean Gaffney, Executive Vice President and Chief Legal Officer

Sean Gaffney became Executive Vice President and Chief Legal Officer of Addus HomeCare in April 2019. Before joining Addus, he served as General Counsel at Encompass Health – Home Health & Hospice. Prior to that, he was Executive Vice President of Corporate Development, General Counsel, and Secretary of BroadJump, LLC, a software start-up.

AI Analysis | Feedback

The key risks to Addus HomeCare's (ADUS) business are primarily rooted in the evolving healthcare regulatory landscape, persistent workforce challenges, and intense market competition.

  1. Regulatory Changes and Reimbursement Pressures: Addus HomeCare relies significantly on government-funded programs like Medicaid and Medicare for a substantial portion of its revenue. Consequently, the company is highly susceptible to changes in government policies, funding levels, and reimbursement models. A prominent example is the Medicaid Access Rule, which mandates that 80% of funds be spent on compensation, posing a risk to the company's margins if reimbursement rates do not increase to offset these costs. Shifts in policy and potential cuts to government healthcare programs could compress Addus's margins and affect its revenue streams.
  2. Workforce Shortages and Wage Inflation: The home healthcare industry, in which Addus operates, faces a significant and ongoing challenge with caregiver recruitment and retention. This shortage leads to increased wage inflation and high turnover rates, directly impacting Addus's operating costs and gross margins, as it is a labor-intensive business. The difficulty in finding and keeping qualified staff can also limit the company's capacity to meet growing demand and expand services.
  3. Increased Competition and Managed Care Organization Dynamics: The home care services market is highly competitive, with many providers vying for market share. Addus HomeCare's increasing reliance on Managed Care Organizations (MCOs) as payor clients also presents a risk. This shift can potentially reduce Addus's bargaining power, leading to lower negotiated rates and increased pressure on profitability and growth.

AI Analysis | Feedback

null

AI Analysis | Feedback

Addus HomeCare (symbol: ADUS) operates in the U.S. market across three main segments: Personal Care, Hospice, and Home Health. The addressable markets for these services are sized as follows:
  • Personal Care: The U.S. personal care services market was valued at approximately USD 455.13 billion in 2025. This market is driven by factors such as the increasing aging population, which requires services to maintain independence and support daily living activities.
  • Hospice: The U.S. hospice market was estimated at USD 29.92 billion in 2024. This market is projected to grow to USD 39.09 billion by 2030, driven by the rising prevalence of chronic diseases among the geriatric population and the increasing need for quality end-of-life care at home.
  • Home Health: The U.S. home healthcare services market size was valued at USD 100.95 billion in 2024. This market is projected to grow to USD 176.30 billion by 2032, with nursing care dominating due to the increasing demand for skilled nursing care at home, particularly among the geriatric population.

AI Analysis | Feedback

Addus HomeCare Corporation (ADUS) is expected to experience future revenue growth over the next two to three years driven by several key factors:

  1. Organic Growth in Personal Care and Hospice Segments: Addus anticipates continued organic expansion within its Personal Care and Hospice segments. The Personal Care segment is expected to benefit from increased service volumes and a rise in authorized hours served, with the impact of Medicaid redeterminations in states like Illinois nearing its conclusion. The Hospice segment is also poised for growth through higher admissions, an increased average daily census, and improved revenue per patient day.
  2. State-Mandated Rate Increases: Favorable reimbursement rate increases, particularly in significant markets such as Illinois and Texas, are identified as a direct contributor to revenue growth. These rate adjustments improve the revenue generated per service provided.
  3. Strategic Acquisitions: Addus HomeCare has a proven track record of growth through strategic acquisitions, and management has indicated plans to continue pursuing selective acquisitions in 2026. The company's strong financial position is expected to support these bolt-on deals, contributing to both market density and expansion into new areas.
  4. Growing Demand for Home-Based Care: The fundamental demographic trend of an aging population, coupled with a societal preference for in-home care due to its value and cost-efficiency compared to institutional settings, is a sustained driver of demand for Addus's services across its segments.
  5. Improved Labor Market Conditions: A softening labor market, especially in key operational states such as Illinois, is expected to alleviate caregiver shortages. This increased availability of workers can enable Addus to serve a greater number of authorized hours and clients, thereby driving volume-based revenue growth.

AI Analysis | Feedback

Share Repurchases

  • Addus HomeCare completed a $250.0 million stock repurchase in 2024.

Share Issuance

  • In June 2024, Addus HomeCare raised $175.6 million through a public offering of 1,725,000 shares of common stock at $108.00 per share.
  • The net proceeds from this offering were intended for the repayment of outstanding indebtedness under its credit facility and for general corporate purposes, including future acquisitions.

Outbound Investments

  • In December 2024, Addus HomeCare completed the acquisition of the personal care operations of Gentiva for approximately $350 million, expanding its market coverage in seven states and entering Texas and Missouri as new markets.
  • During 2023, Addus HomeCare acquired Tennessee Quality Care for $106 million and also acquired Coastal Nursecare of Florida, Inc.
  • In 2022, the company purchased Illinois-based hospice provider JourneyCare Inc. for $85 million and acquired Chicago-based Apple Home Health Ltd.

Capital Expenditures

  • Addus HomeCare continues to invest in technologies that support its operations and enhance the work of its caregivers.
  • The company's capital expenditures for environmental matters were not material during the year ended December 31, 2024.

Better Bets vs. Addus HomeCare (ADUS)

Recent Active Movers

Peer Comparisons

Peers to compare with:

Financials

ADUSENSGAVAHCHEBTSGOPCHMedian
NameAddus Ho.Ensign Aveanna .Chemed BrightSp.Option C. 
Mkt Price94.19153.617.79436.5266.2521.6980.22
Mkt Cap1.78.91.76.013.63.44.7
Rev LTM1,4485,2742,5222,54113,6465,6673,907
Op Inc LTM142449281331366331331
FCF LTM137216129377412213214
FCF 3Y Avg11720052332185243192
CFO LTM145592139444512254349
CFO 3Y Avg12544759388269284277

Growth & Margins

ADUSENSGAVAHCHEBTSGOPCHMedian
NameAddus Ho.Ensign Aveanna .Chemed BrightSp.Option C. 
Rev Chg LTM19.6%19.2%20.5%2.1%28.0%9.3%19.4%
Rev Chg 3Y Avg14.1%18.2%12.0%5.5%21.4%12.0%13.1%
Rev Chg Q7.7%18.4%15.9%1.6%25.6%1.3%11.8%
QoQ Delta Rev Chg LTM1.8%4.3%3.6%0.4%5.7%0.3%2.7%
Op Inc Chg LTM29.8%18.9%64.9%-15.0%110.3%-0.2%24.3%
Op Inc Chg 3Y Avg24.6%16.5%109.8%0.8%697.2%9.7%20.6%
Op Mgn LTM9.8%8.5%11.1%13.0%2.7%5.8%9.2%
Op Mgn 3Y Avg9.2%8.0%8.5%14.5%1.4%6.5%8.2%
QoQ Delta Op Mgn LTM0.1%0.1%0.4%-0.5%0.4%-0.1%0.1%
CFO/Rev LTM10.0%11.2%5.5%17.5%3.7%4.5%7.8%
CFO/Rev 3Y Avg10.0%9.8%2.5%15.9%2.3%5.6%7.7%
FCF/Rev LTM9.5%4.1%5.1%14.8%3.0%3.8%4.6%
FCF/Rev 3Y Avg9.4%4.5%2.1%13.6%1.5%4.8%4.6%

Valuation

ADUSENSGAVAHCHEBTSGOPCHMedian
NameAddus Ho.Ensign Aveanna .Chemed BrightSp.Option C. 
Mkt Cap1.78.91.76.013.63.44.7
P/S1.21.70.72.31.00.61.1
P/Op Inc12.119.85.918.037.110.315.0
P/EBIT11.818.36.117.037.110.114.4
P/E17.224.46.423.043.816.520.1
P/CFO11.815.012.013.526.513.413.4
Total Yield5.8%4.3%15.6%4.8%2.3%6.0%5.3%
Dividend Yield0.0%0.2%0.0%0.4%0.0%0.0%0.0%
FCF Yield 3Y Avg6.8%2.4%3.9%4.6%3.0%4.6%4.3%
D/E0.10.30.90.00.20.40.2
Net D/E0.00.20.80.00.10.30.2

Returns

ADUSENSGAVAHCHEBTSGOPCHMedian
NameAddus Ho.Ensign Aveanna .Chemed BrightSp.Option C. 
1M Rtn1.7%-10.7%6.2%-0.5%13.2%3.6%2.6%
3M Rtn-5.1%-23.2%19.4%15.6%60.8%-23.0%5.3%
6M Rtn-16.5%-15.3%-14.4%0.5%76.7%-33.3%-14.8%
12M Rtn-17.2%0.2%64.9%-20.0%197.5%-31.2%-8.5%
3Y Rtn2.9%66.8%433.2%-19.7%502.3%-27.4%34.9%
1M Excs Rtn-0.3%-14.7%0.0%-2.7%14.8%2.0%-0.1%
3M Excs Rtn-19.4%-37.6%9.3%0.0%37.1%-38.9%-9.7%
6M Excs Rtn-27.3%-22.6%-22.2%-8.3%71.5%-44.3%-22.4%
12M Excs Rtn-42.8%-25.4%35.8%-45.5%184.9%-56.9%-34.1%
3Y Excs Rtn-71.8%-5.8%396.6%-90.3%430.6%-100.4%-38.8%

Comparison Analyses

Financials

Segment Financials

Revenue by Segment
$ Mil20252024202320222021
Personal Care1,089857795707686
Hospice263228207202152
Home Health7170574326
Total1,4231,1551,059951864


Operating Income by Segment
$ Mil20252024202320222021
Personal Care207174158125122
Hospice6752455142
Home Health128733
Depreciation and amortization-16-14-14-14-14
Other general and administrative expenses-132-118-104-96-88
Total139103916966


Assets by Segment
$ Mil2011201020092008
Home & Community11812211891
Corporate2316 20
Home Health14292724
General corporate expenses & corporate depreciation  16 
Total155167161136


Price Behavior

Price Behavior
Market Price$94.23 
Market Cap ($ Bil)1.7 
First Trading Date10/28/2009 
Distance from 52W High-23.2% 
   50 Days200 Days
DMA Price$94.18$106.24
DMA Trenddowndown
Distance from DMA0.1%-11.3%
 3M1YR
Volatility25.6%30.8%
Downside Capture34.4166.20
Upside Capture0.7425.64
Correlation (SPY)8.2%16.8%
ADUS Betas & Captures as of 5/31/2026

 1M2M3M6M1Y3Y
Beta-0.350.210.420.160.540.56
Up Beta0.000.06-0.220.020.380.54
Down Beta2.361.371.220.460.550.23
Up Capture-100%-1%11%-20%27%35%
Bmk +ve Days13283667141432
Stock +ve Days9202855117375
Down Capture-112%43%91%54%88%94%
Bmk -ve Days7132757109318
Stock -ve Days11213567130371

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with ADUS
ADUS-17.6%30.7%-0.62-
Sector ETF (XLV)14.0%15.0%0.6625.6%
Equity (SPY)26.5%12.4%1.6117.1%
Gold (GLD)24.2%27.5%0.774.4%
Commodities (DBC)19.8%18.8%0.83-9.4%
Real Estate (VNQ)11.0%13.7%0.5217.4%
Bitcoin (BTCUSD)-40.0%42.4%-1.088.3%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with ADUS
ADUS0.7%34.8%0.09-
Sector ETF (XLV)5.4%14.7%0.1933.0%
Equity (SPY)13.5%17.1%0.6233.3%
Gold (GLD)17.1%18.3%0.763.8%
Commodities (DBC)7.5%19.4%0.291.6%
Real Estate (VNQ)1.9%18.9%0.0028.4%
Bitcoin (BTCUSD)11.0%54.2%0.4015.6%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with ADUS
ADUS16.8%39.5%0.52-
Sector ETF (XLV)9.4%16.6%0.4634.2%
Equity (SPY)15.3%18.0%0.7333.8%
Gold (GLD)12.3%16.1%0.634.3%
Commodities (DBC)5.9%18.0%0.268.0%
Real Estate (VNQ)5.3%20.7%0.2226.8%
Bitcoin (BTCUSD)60.0%66.8%1.008.7%

Smart multi-asset allocation framework can stack odds in your favor. Learn How

Short Interest

Short Interest: As Of Date5292026
Short Interest: Shares Quantity1.0 Mil
Short Interest: % Change Since 51520265.2%
Average Daily Volume0.2 Mil
Days-to-Cover Short Interest5.0 days
Basic Shares Quantity18.2 Mil
Short % of Basic Shares5.3%

Earnings Returns History

Updated 6/4/2026
Expand for More
 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
5/4/2026-1.7%-2.3%-11.6%
2/23/2026-10.6%-10.5%-15.6%
11/3/2025-5.7%-5.2%-4.1%
8/4/20259.0%4.7%5.7%
5/5/20254.1%5.9%7.3%
2/24/2025-10.4%-12.7%-12.7%
11/4/2024-3.7%-0.8%-4.2%
8/5/20245.8%6.6%10.9%
...
SUMMARY STATS   
# Positive131211
# Negative111213
Median Positive5.8%6.8%7.3%
Median Negative-5.0%-5.6%-7.1%
Max Positive12.9%13.0%17.4%
Max Negative-10.6%-17.9%-15.6%
Collapse to Preview
 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
5/4/2026-1.7%-2.3%-11.6%
2/23/2026-10.6%-10.5%-15.6%
11/3/2025-5.7%-5.2%-4.1%
8/4/20259.0%4.7%5.7%
5/5/20254.1%5.9%7.3%
2/24/2025-10.4%-12.7%-12.7%
11/4/2024-3.7%-0.8%-4.2%
8/5/20245.8%6.6%10.9%
5/6/20246.8%13.0%17.2%
2/26/20245.5%9.6%17.4%
10/30/2023-5.2%2.0%5.4%
7/31/20231.5%2.9%-2.5%
5/1/2023-2.6%-5.8%1.5%
2/27/20232.6%-2.2%-1.5%
10/31/20226.0%7.2%7.7%
8/1/20220.5%-1.9%-7.1%
5/3/2022-2.3%-7.0%-4.2%
2/24/202212.9%7.0%8.5%
11/1/2021-3.1%8.0%-11.2%
8/3/202111.3%9.3%5.7%
5/3/2021-5.9%-8.3%-9.3%
2/25/2021-5.0%-17.9%-5.0%
11/3/20208.0%0.4%0.9%
8/10/20200.7%-5.4%-9.0%
SUMMARY STATS   
# Positive131211
# Negative111213
Median Positive5.8%6.8%7.3%
Median Negative-5.0%-5.6%-7.1%
Max Positive12.9%13.0%17.4%
Max Negative-10.6%-17.9%-15.6%

SEC Filings

Expand for More
Report DateFiling DateFiling
03/31/202605/05/202610-Q
12/31/202502/24/202610-K
09/30/202511/04/202510-Q
06/30/202508/05/202510-Q
03/31/202505/06/202510-Q
12/31/202402/25/202510-K
09/30/202411/05/202410-Q
06/30/202408/06/202410-Q
03/31/202405/07/202410-Q
12/31/202302/27/202410-K
09/30/202310/31/202310-Q
06/30/202308/01/202310-Q
03/31/202305/02/202310-Q
12/31/202202/28/202310-K
09/30/202211/01/202210-Q
06/30/202208/02/202210-Q
Collapse to Preview
Report DateFiling DateFiling
03/31/202605/05/202610-Q
12/31/202502/24/202610-K
09/30/202511/04/202510-Q
06/30/202508/05/202510-Q
03/31/202505/06/202510-Q
12/31/202402/25/202510-K
09/30/202411/05/202410-Q
06/30/202408/06/202410-Q
03/31/202405/07/202410-Q
12/31/202302/27/202410-K
09/30/202310/31/202310-Q
06/30/202308/01/202310-Q
03/31/202305/02/202310-Q
12/31/202202/28/202310-K
09/30/202211/01/202210-Q
06/30/202208/02/202210-Q
03/31/202205/03/202210-Q
12/31/202102/25/202210-K
09/30/202111/02/202110-Q
06/30/202108/04/202110-Q
03/31/202105/07/202110-Q
12/31/202003/01/202110-K
09/30/202011/06/202010-Q
06/30/202008/10/202010-Q
03/31/202008/10/202010-Q
12/31/201908/10/202010-K
09/30/201911/08/201910-Q
06/30/201908/08/201910-Q

Insider Activity

Updated 6/11/2026
Expand for More
#OwnerTitleHoldingActionFiling DatePriceSharesTransacted
Value
Value of
Held Shares
Form
1Lopez, Esteban DirectSell522202693.0025023,250297,600Form
2Lopez, Esteban DirectSell521202693.0025023,250320,850Form
3Blessing, Cliff DonaldEVP, Chief Development OfficerDirectSell422202693.6117816,6631,140,451Form
4Raines, MonicaEVP, CCO and Quality OfficerDirectSell3032026102.1522422,8821,386,891Form
5Raines, MonicaEVP, CCO and Quality OfficerDirectSell2262026105.3621923,0741,454,073Form
Collapse to Preview
#OwnerTitleHoldingActionFiling DatePriceSharesTransacted
Value
Value of
Held Shares
Form
1Lopez, Esteban DirectSell522202693.0025023,250297,600Form
2Lopez, Esteban DirectSell521202693.0025023,250320,850Form
3Blessing, Cliff DonaldEVP, Chief Development OfficerDirectSell422202693.6117816,6631,140,451Form
4Raines, MonicaEVP, CCO and Quality OfficerDirectSell3032026102.1522422,8821,386,891Form
5Raines, MonicaEVP, CCO and Quality OfficerDirectSell2262026105.3621923,0741,454,073Form
6Stevenson, Roberton JamesEVP, Chief HR OfficerDirectSell2262026105.3628429,9221,478,201Form
7Blessing, Cliff DonaldEVP, Chief Development OfficerDirectSell2262026105.3617718,6491,302,355Form
8Wattenbarger, Michael DEVP, Chief Information OfficerDirectSell2262026105.3630031,608995,020Form
9Tucker, David WEVP, Chief Strategy OfficerDirectSell2262026105.3637939,9311,098,167Form
10Anderson, DarbyEVP, Chief Govt Rel OfficerDirectSell2262026105.3639641,7234,872,479Form
11Gaffney, SeanEVP, Chief Legal OfficerDirectSell2262026105.3644246,5692,115,629Form
12Poff, BrianEVP, Chief Financial OfficerDirectSell2262026105.3682086,3956,710,589Form
13Allison, R DirkChairman and CEODirectSell2262026105.362,364249,07119,296,684Form
14Raines, MonicaEVP, CCO and Quality OfficerDirectSell2262026106.9943746,7551,500,000Form
15Stevenson, Roberton JamesEVP, Chief HR OfficerDirectSell2262026107.3556760,8671,536,608Form
16Blessing, Cliff DonaldEVP, Chief Development OfficerDirectSell2262026107.1435037,4991,343,321Form
17Wattenbarger, Michael DEVP, Chief Information OfficerDirectSell2262026107.3559263,5511,046,018Form
18Tucker, David WEVP, Chief Strategy OfficerDirectSell2262026107.3570475,5741,159,595Form
19Anderson, DarbyEVP, Chief Govt Rel OfficerDirectSell2262026106.9873378,4164,989,761Form
20Gaffney, SeanEVP, Chief Legal OfficerDirectSell2262026106.9881787,4032,195,444Form
21Poff, BrianEVP, Chief Financial OfficerDirectSell2262026106.982,041218,3466,901,494Form
22Allison, R DirkChairman and CEODirectSell2262026106.984,988533,61619,846,288Form
23Raines, MonicaEVP, CCO and Quality OfficerDirectSell2242026114.9144651,2501,661,254Form
24Stevenson, Roberton JamesEVP, Chief HR OfficerDirectSell2242026114.9156164,4651,709,976Form
25Blessing, Cliff DonaldEVP, Chief Development OfficerDirectSell2242026114.9137142,6321,480,960Form
26Wattenbarger, Michael DEVP, Chief Information OfficerDirectSell2242026114.9157766,3031,187,710Form
27Tucker, David WEVP, Chief Strategy OfficerDirectSell2242026114.9165875,6111,322,154Form
28Anderson, DarbyEVP, Chief Govt Rel OfficerDirectSell2242026114.9166676,5305,443,861Form
29Gaffney, SeanEVP, Chief Legal OfficerDirectSell2242026114.9173784,6892,452,064Form
30Poff, BrianEVP, Chief Financial OfficerDirectSell2242026114.911,858213,5037,647,605Form
31Allison, R DirkChairman and CEODirectSell2242026114.914,535521,11721,890,585Form
32Lopez, Esteban DirectSell12162025115.1815017,278426,178Form
33Lopez, Esteban DirectSell12082025112.7816618,721434,203Form
34Anderson, DarbyEVP, Chief Govt Rel OfficerDirectSell11202025109.0020,0002,180,0004,811,696Form
35Bickham, W BradleyPresident and COODirectSell9032025115.754,000463,0004,352,779Form
36Allison, R DirkChairman and CEODirectSell9032025115.8325,0002,895,75019,281,176Form
37Poff, BrianEVP, Chief Financial OfficerDirectSell8262025116.827,739904,0886,656,533Form
38Allison, R DirkChairman and CEODirectSell8212025114.9525,0002,873,85119,135,363Form
39Hill-Milbourne, Veronica DirectSell8212025114.931,571180,555582,350Form
40Bickham, W BradleyPresident and COODirectSell8152025115.349,0001,038,1004,902,716Form
41Lopez, Esteban DirectSell8112025109.0052256,898437,744Form
42Stevenson, Roberton JamesEVP & Chief HR OfficerDirectSell6172025112.9922825,7621,421,866Form
43Tucker, David WEVP / Chief Strategy OfficerDirectSell6122025115.432,403277,3781,008,281Form
Core Cache Last Updated: 6/21/2026